Summary
- Current Price
- As of today, VKTX price is $34.87, up +2.62% on
- Current Price All-Time High
- VKTX price is currently -64.92% below its historical high of $99.41 set on
- Market Cap
- VKTX current market cap is $4B, up +36.49% over the past 365 days
- Revenue
- VKTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for VKTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Viking Therapeutics, Inc. |
| Ticker | NASDAQ: VKTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vikingtherapeutics.com |
| Employees | 48 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $34.87 | |
| Price, 1D Change | +2.62% | |
| $4B | ||
| - | ||
| - | ||
| 1.14 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.19 | ||
| EPS, 1Y Change | -216.51% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.19 | ||
| EPS Estimate | -$4.61 | N/A |
| EPS Est. Change | -44.29% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $34.87 | |
| Price Target | $95.00 | - |
| Price Tgt. Change | +172.44% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.96 | -$1.01 | -4.93% | |
| -$2.61 | -$3.19 | -22.14% | |
| -$4.61 | N/A | -44.29% | |
| -$4.32 | N/A | -35.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $34.87 | |
| $33.50 | ||
| $35.43 | ||
| $33.60 | ||
| $34.11 | ||
| -$0.17 | ||
| 1.14 | ||
| $1.50 | ||
| 54.29 | ||
| 40.63% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.19 | ||
| -$431.00K | ||
| - | ||
| -$393.34M | ||
| - | ||
| -$359.64M | ||
| - | ||
| -$392.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 9.33 | ||
| 9.33 | ||
| - | ||
| - | ||
| 29.43 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 9.96 | ||
| -6.38 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $639.06M | ||
| $705.74M | ||
| $715.73M | ||
| $715.60M | ||
| $76.67M | ||
| $76.67M | ||
| $137.00K | ||
| $137.00K | ||
| $53.25M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $359.64M | ||
| $392.91M | ||
| $431.00K | ||
| $0.00 | ||
| $431.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$278.69M | ||
| $341.39M | ||
| $76.44M | ||
| $0.00 | ||
| -$278.69M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Canaccord Genuity | → | |
| Lake Street | ||
| BTIG | → | |
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | ||
| JP Morgan | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with VKTX
FAQ
- What is the ticker symbol for Viking Therapeutics, Inc.?
- The ticker symbol for Viking Therapeutics, Inc. is NASDAQ:VKTX
- Does Viking Therapeutics, Inc. pay dividends?
- No, Viking Therapeutics, Inc. does not pay dividends
- What sector is Viking Therapeutics, Inc. in?
- Viking Therapeutics, Inc. is in the Healthcare sector
- What industry is Viking Therapeutics, Inc. in?
- Viking Therapeutics, Inc. is in the Biotechnology industry
- What country is Viking Therapeutics, Inc. based in?
- Viking Therapeutics, Inc. is headquartered in United States
- When did Viking Therapeutics, Inc. go public?
- Viking Therapeutics, Inc. initial public offering (IPO) was on April 28, 2015
- Is Viking Therapeutics, Inc. in the S&P 500?
- No, Viking Therapeutics, Inc. is not included in the S&P 500 index
- Is Viking Therapeutics, Inc. in the NASDAQ 100?
- No, Viking Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Viking Therapeutics, Inc. in the Dow Jones?
- No, Viking Therapeutics, Inc. is not included in the Dow Jones index
- When was Viking Therapeutics, Inc. last earnings report?
- Viking Therapeutics, Inc.'s most recent earnings report was on July 29, 2026
- When does Viking Therapeutics, Inc. report earnings?
- The next expected earnings date for Viking Therapeutics, Inc. is October 28, 2026
Data Sources & References
- VKTX Official Website www.vikingtherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1607678/000119312526046876/0001193125-26-046876-index.htm
- VKTX Profile on Yahoo Finance finance.yahoo.com/quote/VKTX
- VKTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vktx